Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001601830-24-000119
Filing Date
2024-08-08
Accepted
2024-08-08 17:23:10
Documents
1
Period of Report
2024-08-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1723152181.html 4  
1 FORM 4 wk-form4_1723152181.xml 4 3705
  Complete submission text file 0001601830-24-000119.txt   5296
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address
Borgeson Blake (Reporting) CIK: 0001856094 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40323 | Film No.: 241189707